Product
Covid-19 vaccine
Aliases
SARS-CoV-2 vaccine
2 clinical trials
4 indications
Indication
COVID-19 infectionIndication
InfluenzaIndication
HumanIndication
COVID-19Clinical trial
A Binded, Randomised, Controlled Cross-over Trial to Assess the Safety and Efficacy of Mucosal Covid-19 and Influenza VaccinesStatus: Not yet recruiting, Estimated PCD: 2024-04-21
Clinical trial
Immunogenicity Study of the Covid-19 (Recombinante) Vaccine - Fiocruz/AstraZeneca When Administered With a 4 or 8 Weeks Interval Between the First Two Doses.Status: Active (not recruiting), Estimated PCD: 2022-03-31